PHAT stock

Phathom Pharmaceuticals Inc (PHAT) revenue is $49.5M

Phathom Pharmaceuticals Inc (PHAT) revenue is $49.5M as of 2025-09-30. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.

Read the full PHAT research page for quote, filings, and the rest of the model. This satellite exists so “Phathom Pharmaceuticals Inc revenue” can rank with the actual number, then send you to /stock/phat.

Full PHAT analysis